The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, ...

India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

Trump announced reciprocal tariffs that could take effect against US trading partners, including India, as soon as April. The ...

India’s pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

Indian pharma exporters must unite and report challenges in exports to overcome trade barriers: Raja Bhanu: Shardul Nautiyal, Mumbai Friday, February 14, 2025, 08:00 Hrs [IST] The ...

India's pharmaceutical exports are projected to reach USD 65 billion by 2030, with a target of USD 350 billion by 2047, ...

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...

India’s rapid digitalization and youthful population position it for long-term economic expansion, with its internet economy ...

The implementation of the revised Schedule M marks a critical step towards enhancing the quality and safety of pharmaceutical ...

Stock analysts noted Natco Pharma’s missed consensus Q3 estimates on both revenue and Ebitda margin fronts due to lack of ...

India's pharmaceutical exports are projected to double from approximately $27 billion in 2023 to reach $65 billion by 2030, ...